PRYZM delivers the data you need for pharmaceutical drugs in use and development around the world.
Using advanced analytics, we collect, refine, and index data from dozens of trusted sources worldwide for your pre-clinical, clinical, or approved pharmaceuticals in use worldwide.
Originator, Developer, Leadership, and Product Description
MOA, Administration Methods, Indications, and Phase
News Articles, Scientific History, and Clinical Trial History
Trials by Disease Area
Visualizations and charts of known trials
When developing a compound or new therapeutic agent, success depends greatly on understanding the competitive landscape. Knowing what treatments have been approved, where they are being used, and how many similar mechanisms of action are in development or already on the market can drive a launch strategy.
PRYZM collects data country by country and indexes it to create searchable, streamlined, and easy-to-read reports that contain all the information you need in one place. Users have multiple search options and can search by brand name, brand owner, ATC (anatomical therapeutic chemical code), or search country-to-country.
Users have access to an approved pharmaceuticals database that covers 80 countries and contains information on thousands of marketed pharmaceutical products that required an approval. These pharmaceuticals are indexed to our global clinical trials data by drug name and company to easily deliver the full picture of R&D and commercial activity for any given pharmaceutical product on the market, in R&D, or both. Our newest addition to the PRYZM data set is our robust preclinical library to capture drugs in preclinical development worldwide.